ストックスクリーナーアプリを入手
191.95
0.30%
1.0529
前日終値:
$190.90
開ける：
$191.43
24時間の取引高:
73,162
Relative Volume:
0.09
時価総額：
$12.25B
収益：
$13.84B
当期純損益:
$1.10B
株価収益率:
18.42
EPS:
10.4185
ネットキャッシュフロー:
$1.49B
1週間 パフォーマンス:
+4.63%
1か月 パフォーマンス:
+6.34%
6か月 パフォーマンス:
+29.19%
1年 パフォーマンス:
+47.17%
1日の値動き範囲:
$189.99
$192.20
1週間の範囲:
$180.47
$192.08
52週間の値動き範囲:
$101.00
$247.49
Davita Inc Stock (DVA) Company Profile
Compare DVA vs HCA, THC, FMS, EHC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
192.00 | 11.58B | 13.84B | 1.10B | 1.49B | 10.42 |
HCA
Hca Healthcare Inc
|
427.88 | 92.43B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
264.93 | 21.23B | 21.46B | 2.65B | 3.35B | 19.23 |
FMS
Fresenius Medical Care Ag Adr
|
23.00 | 11.90B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
123.94 | 12.01B | 6.07B | 793.80M | 464.40M | 5.9914 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-03-06 | 開始されました | Barclays | Equal Weight |
| 2023-08-07 | アップグレード | UBS | Neutral → Buy |
| 2022-11-01 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2022-10-31 | ダウングレード | UBS | Buy → Neutral |
| 2022-08-19 | 再開されました | UBS | Buy |
| 2022-06-21 | 繰り返されました | BofA Securities | Underperform |
| 2021-09-10 | 開始されました | Cowen | Market Perform |
| 2021-08-12 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2021-03-26 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2021-01-05 | ダウングレード | BofA Securities | Buy → Neutral |
| 2020-01-24 | アップグレード | Goldman | Neutral → Buy |
| 2019-11-07 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2019-10-25 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2019-09-11 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2019-07-26 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2019-01-08 | アップグレード | UBS | Sell → Neutral |
| 2019-01-03 | 開始されました | Deutsche Bank | Buy |
| 2018-12-14 | 開始されました | Barclays | Overweight |
| 2018-11-28 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2018-11-16 | 開始されました | UBS | Sell |
| 2018-11-08 | ダウングレード | Raymond James | Strong Buy → Mkt Perform |
| 2018-09-13 | アップグレード | JP Morgan | Underweight → Neutral |
| 2018-01-04 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2017-12-12 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2017-12-11 | アップグレード | Citigroup | Neutral → Buy |
| 2017-12-07 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2017-11-08 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2017-10-09 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2017-06-26 | ダウングレード | Jefferies | Buy → Hold |
| 2016-12-13 | ダウングレード | Robert W. Baird | Outperform → Neutral |
すべてを表示
Davita Inc (DVA) 最新ニュース
DaVita Inc. stock advances as Q2 2026 earnings and guidance underpin strong valuation - ad-hoc-news.de
DaVita Community Care Report 2025: Our Journey to Net Zero - ACCESS Newswire
DaVita stock heads into the open after a 1.9% gain - ad-hoc-news.de
DaVita to pay $15M to settle data breach lawsuit - Tri-Cities Area Journal of Business
DaVita Inc. stock gains as guidance and earnings support strong 2026 outlook - ad-hoc-news.de
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
Here's Why You Should Retain DaVita Stock in Your Portfolio for Now - Yahoo Finance
DaVita stock heads into the open after a 0.9% gain - ad-hoc-news.de
DaVita Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Commitment to Helping Communities Thrive: DaVita Community Care Report 2025 - accessnewswire.com
DaVita Inc. stock holds near recent highs on solid Q2 2026 earnings and guidance - ad-hoc-news.de
DaVita stock heads into the open after a flat prior close - ad-hoc-news.de
DaVita Inc. stock gains support from solid Q2 2026 earnings - ad-hoc-news.de
DaVita Inc. (DVA) Stock Analysis: Evaluating the 18.72% Upside Potential for Healthcare Investors - DirectorsTalk Interviews
DaVita Inc. stock gains on solid Q1 figures and buybacks - ad-hoc-news.de
DaVita $15M Data Breach Settlement Hits 2.4M Patients - tech-insider.org
DaVita stock gains as Humana expands kidney care - ad-hoc-news.de
Healthcare August recap: Moderna jumps 156% as biotech shines; DaVita sinks - Seeking Alpha
DaVita $15M Data Breach Settlement 2026: What It Pays - shattered.io
NewsDaVita to pay $15 million to settle data breach lawsuit affecting millions of dialysis patients - teiss
DaVita Community Care Report 2025: Leading With Integrity and Accountability - ACCESS Newswire
DaVita Reaches Preliminary Settlement Class Agreement Following Ransomware Attack - Benzinga
DaVita (DVA) Has Investors Asking A Fresh Question - Yahoo Finance
DaVita Inc. stock gains support from higher earnings and steady guidance - ad-hoc-news.de
DaVita (DVA) Q2 2026 Earnings Call Transcript - Fortune
DaVita agrees to pay $15M to settle claims from data breach - MedTech Dive
DaVita Inc. stock holds near 179 dollars after strong 2026 earnings momentum - ad-hoc-news.de
Why Is DaVita HealthCare (DVA) Down 4.9% Since Last Earnings Report? - Yahoo Finance
Do Options Traders Know Something About DaVita Stock We Don't? - TradingView
DaVita Inc. stock gains after data breach settlement and partnership expansion - ad-hoc-news.de
DaVita (NYSE:DVA): Is the Humana Deal Unlocking More Value? - Kalkine Media
DaVita Agrees to Pay $15 Million to Settle Data Breach Litigation - The HIPAA Journal
DaVita stock trades around $180 as Q2 2026 growth and kidney-care partnership shape expectations - AD HOC NEWS
DaVita Inc. stock underperforms Monday when compared to competitors - MarketWatch
DaVita stock holds $180.72 as earnings beat and guidance stand out - ad-hoc-news.de
Zacks Industry Outlook Highlights DaVita, LifeStance Health, Option Care Health, and Aveanna Healthcare - Yahoo Finance
DaVita Inc. (DVA) Stock Analysis: Strong EPS and Growth Potential Highlight Investment Opportunity - DirectorsTalk Interviews
At US$180, Is DaVita Inc. (NYSE:DVA) Worth Looking At Closely? - Moomoo
Will DaVita’s (DVA) Expanded Humana CKD Partnership Reshape Its Value-Based Care Narrative? - simplywall.st
DaVita stock steadies as new Humana partnership follows strong Q2 results - ad-hoc-news.de
Enterprise value to revenue forward of DaVita Inc. – NYSE:DVA - TradingView
Davita Inc. Announces New Value-Based Partnership with Humana Inc. to Expand Care for Patients with Chronic Kidney Disease - marketscreener.com
DaVita partners with Humana on kidney disease care program - investing.com
DaVita Defeats Nurse Overtime Collective Bid - law360.com
DaVita stock holds a solid valuation as investors digest recent earnings and ratings - ad-hoc-news.de
DaVita dialysis clinic in Novi has repeated deficiencies as families demand answers after 2 deaths - WXYZ Channel 7
Wealthfront Advisers LLC Buys Shares of 10,596 DaVita Inc. $DVA - MarketBeat
Mitsubishi UFJ Asset Management Co. Ltd. Takes Position in DaVita Inc. $DVA - MarketBeat
Danske Bank A S Invests $13.11 Million in DaVita Inc. $DVA - MarketBeat
DaVita Inc. stock underperforms Thursday when compared to competitors - MarketWatch
DaVita stock steadies after Q2 revenue growth but EPS outlook disappoints - Ad-hoc-news.de
Davita Inc (DVA) 財務データ
収益
当期純利益
現金流量
EPS
0.52%
大文字化:
|
ボリューム (24 時間):